Scott Coleman Email & Phone Number
Chief Development Officer (CDO) @ Akrevia Therapeutics, Inc.
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Scott Coleman Location
- Lexington, MA, US
Scott Coleman Work
- 2023 -now Chief Development Officer (CDO) @
- 2022 -now Senior Vice President Nonclinical Development @
- 2020 -2022 Vice President Nonclinical Development @
- 2018 -2020 Senior Director Preclinical Safety Evaluation @
- 2015 -2018 Head of Nonclinical Development @
- 2015 -2015 Senior Director - Discovery Toxicology and DMPK @
- 2011 -2015 Senior Director - Discovery Toxicology and DMPK @ Cubist Pharmaceuticals
- 2008 -2011 Director - Discovery Toxicology and DMPK @ Cubist Pharmaceuticals
- 2006 -2008 Senior Scientist @ Cubist Pharmaceuticals
- 2001 -2006 Senior Scientist @ Millennium Pharmaceuticals
Scott Coleman Education
- North Carolina State University
Doctor of Philosophy (Toxicology)
1996-2000 - Northeastern University
Bachelor of Science (Toxicology)
1988-1993 - University of Massachusetts Medical School
Scott Coleman Skills
- Biotechnology
- Cross Functional Team Leadership
- Chromatography
- R&d
- EHS
- Mobiles Marketing
Scott Coleman Summary
- Scott Coleman, based in Lexington, MA, US, is currently a Chief Development Officer (CDO) at Xilio Therapeutics, Inc.. Scott Coleman brings experience from previous roles at Xilio Therapeutics, Inc., Acceleron Pharma and Spero Therapeutics. Scott Coleman holds a 1996 - 2000 Doctor of Philosophy in Toxicology @ North Carolina State University. With a robust skill set that includes Biotechnology, Cross Functional Team Leadership, Chromatography, R&d, EHS and more. Scott Coleman has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Scott Coleman?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co